Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19

• Main Authors: Sergey V Efimov (Author), Natallia V Matsiyeuskaya (Author), Olga V Boytsova (Author), Luydmila Yu Akhieva (Author), Elena V Kuntsevich (Author), Anastasia A Troshina (Author), Elena I Kvasova (Author), Anton A Tikhonov (Author), Nadezhda F Khomyakova (Author), Francisco Harrison (Author), Jean-François Rossi (Author), Timothy C Hardman (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Evidence-based therapies used to treat coronavirus disease (COVID-19) remain limited. Azoximer bromide (AZB; Polyoxidonium®) is an immunomodulating molecule frequently used in the Russian Federation. It offers demonstrable therapeutic benefit in upper respiratory tract infections. This s...